Literature DB >> 35083854

SARS-CoV-2 Omicron emergence urges for reinforced One-Health surveillance.

Xavier Montagutelli1, Sylvie van der Werf2,3, Felix A Rey4, Etienne Simon-Loriere5.   

Abstract

SARS-CoV-2 Omicron harbors substitutions in the receptor binding domain of the spike which strongly suggest its capacity to infect rodents. Wild animal reservoirs could favor the emergence of new variants with risks of spillback to humans and should be closely monitored.
© 2022 The Authors. Published under the terms of the CC BY 4.0 license.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35083854      PMCID: PMC8899904          DOI: 10.15252/emmm.202115558

Source DB:  PubMed          Journal:  EMBO Mol Med        ISSN: 1757-4676            Impact factor:   12.137


Throughout its short history, SARS‐CoV‐2 has demonstrated its capacity to jump back and forth between humans and animals. Following its emergence from a likely bat reservoir, with or without an intermediate host, the virus has successfully infected an array of domestic and wild animals (Chandler et al, 2021; OIE, 2022). In 2020, the infection of mink farms in multiple countries was a strong reminder of the importance of One‐Health surveillance. The constitution of a non‐human reservoir from where the virus could spill back into humans is a major concern, as exemplified by multiple viruses, including influenza, with documented cases of human‐to‐swine‐to‐human transmission (Glud et al, 2021). Importantly, the intensive circulation of an emerging virus in a new host leads to the accumulation of amino acid changes, some reflecting adaptation to this novel environment, which could result in the evolution of variants with unpredictable properties with regard to human infection. As a case in point, SARS‐CoV‐2 spillback from minks to humans in Denmark was associated with lower capability of pre‐existing human antibodies to neutralize the variant (Larsen et al, 2021). Living close to humans, sometimes in large numbers, rodents are susceptible to infectious diseases that can threaten human health, such as plague, leptospirosis, or Lassa fever. In March 2021, we reported that mice, which are not susceptible to the initial SARS‐CoV‐2 genotype, were permissive to viral replication of the Alpha, Beta, and Gamma Variants of Concern (VOC; preprint: Montagutelli et al, 2021b), a finding that was later confirmed by others. We also demonstrated that Beta could be transmitted between mice by direct contact (preprint: Montagutelli et al, 2021b). Central to this host range expansion is the N501Y substitution in the receptor‐binding domain of the spike, a convergent change detected in many SARS‐CoV‐2 lineages. The newly emerged Omicron VOC harbors not only N501Y but also changes at residues 493 and 498 to basic amino acids as seen recurrently in mouse‐adapted strains (Fig 1), arguing for its capacity to replicate in mice. The intense circulation of variants presenting these features is a stark warning of the risk of reservoirs of SARS‐CoV‐2 in wild rodents, and this risk could extend to other animal species with sufficient population densities. In fact, the genomic variations of Omicron are so extensive that they could have been acquired upon circulation in an animal reservoir, a credible alternative hypothesis for its emergence process.
Figure 1

Amino acid changes in the receptor–binding domain (RBD) of the spike of SARS‐CoV‐2

Residues 417, 493, 498, and 501 are also modified in several mouse‐adapted SARS‐CoV‐2 strains. A: Table of changes in section of the RBD for pandemic lineages and mouse‐adapted strains. B: Mapping onto the X‐ray structure of the RBD (PDB 6M0J) shown as a white surface with the human ACE2 contact area highlighted in yellow (left panels). The RBD residues recurrently observed as undergoing changes upon adaptation of SARS‐CoV‐2 to mice are marked in blue in the middle panels, while the multiple changes observed in the RBD of the Omicron variant spike are indicated in purple in the right panels. Mouse‐adapted strains: MACo3 from Montagutelli et al (preprint: Montagutelli et al, 2021a), WBP‐1 from Huang et al (2021), MASCp36 from Sun et al (2021), HRB26M, which also contains a deletion near the furin site, from Wang et al (2020) and MA10 from Leist et al (2020). Other changes outside of the RBD were also noted in mouse‐adapted SARS‐CoV‐2 genomes.

Amino acid changes in the receptor–binding domain (RBD) of the spike of SARS‐CoV‐2

Residues 417, 493, 498, and 501 are also modified in several mouse‐adapted SARS‐CoV‐2 strains. A: Table of changes in section of the RBD for pandemic lineages and mouse‐adapted strains. B: Mapping onto the X‐ray structure of the RBD (PDB 6M0J) shown as a white surface with the human ACE2 contact area highlighted in yellow (left panels). The RBD residues recurrently observed as undergoing changes upon adaptation of SARS‐CoV‐2 to mice are marked in blue in the middle panels, while the multiple changes observed in the RBD of the Omicron variant spike are indicated in purple in the right panels. Mouse‐adapted strains: MACo3 from Montagutelli et al (preprint: Montagutelli et al, 2021a), WBP‐1 from Huang et al (2021), MASCp36 from Sun et al (2021), HRB26M, which also contains a deletion near the furin site, from Wang et al (2020) and MA10 from Leist et al (2020). Other changes outside of the RBD were also noted in mouse‐adapted SARS‐CoV‐2 genomes. We thus call for practical reinforcements of collaborative efforts of surveillance at the human–animal interface and its environment—both in high‐density cities and rural places for rodents—as a critical determinant of current and future pandemic risk.

Author contributions

XM and ES‐L designed and coordinated the study. FAR performed structural analysis. XM and ES‐L wrote and revised the manuscript with input from SW and FAR.
  8 in total

Review 1.  Zoonotic and reverse zoonotic transmission of viruses between humans and pigs.

Authors:  Helena Aagaard Glud; Sophie George; Kerstin Skovgaard; Lars Erik Larsen
Journal:  APMIS       Date:  2021-10-18       Impact factor: 3.428

2.  Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.

Authors:  Kun Huang; Yufei Zhang; Xianfeng Hui; Ya Zhao; Wenxiao Gong; Ting Wang; Shaoran Zhang; Yong Yang; Fei Deng; Qiang Zhang; Xi Chen; Ying Yang; Xiaomei Sun; Huanchun Chen; Yizhi J Tao; Zhong Zou; Meilin Jin
Journal:  EBioMedicine       Date:  2021-05-13       Impact factor: 8.143

3.  A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.

Authors:  Sarah R Leist; Kenneth H Dinnon; Alexandra Schäfer; Longping V Tse; Kenichi Okuda; Yixuan J Hou; Ande West; Caitlin E Edwards; Wes Sanders; Ethan J Fritch; Kendra L Gully; Trevor Scobey; Ariane J Brown; Timothy P Sheahan; Nathaniel J Moorman; Richard C Boucher; Lisa E Gralinski; Stephanie A Montgomery; Ralph S Baric
Journal:  Cell       Date:  2020-09-23       Impact factor: 41.582

4.  Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread, Denmark, June to November 2020.

Authors:  Helle Daugaard Larsen; Jannik Fonager; Frederikke Kristensen Lomholt; Tine Dalby; Guido Benedetti; Brian Kristensen; Tinna Ravnholt Urth; Morten Rasmussen; Ria Lassaunière; Thomas Bruun Rasmussen; Bertel Strandbygaard; Louise Lohse; Manon Chaine; Karina Lauenborg Møller; Ann-Sofie Nicole Berthelsen; Sarah Kristine Nørgaard; Ute Wolff Sönksen; Anette Ella Boklund; Anne Sofie Hammer; Graham J Belsham; Tyra Grove Krause; Sten Mortensen; Anette Bøtner; Anders Fomsgaard; Kåre Mølbak
Journal:  Euro Surveill       Date:  2021-02

5.  SARS-CoV-2 Omicron emergence urges for reinforced One-Health surveillance.

Authors:  Xavier Montagutelli; Sylvie van der Werf; Felix A Rey; Etienne Simon-Loriere
Journal:  EMBO Mol Med       Date:  2022-01-27       Impact factor: 12.137

6.  Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice.

Authors:  Jinliang Wang; Lei Shuai; Chong Wang; Renqiang Liu; Xijun He; Xianfeng Zhang; Ziruo Sun; Dan Shan; Jinying Ge; Xijun Wang; Ronghong Hua; Gongxun Zhong; Zhiyuan Wen; Zhigao Bu
Journal:  Protein Cell       Date:  2020-10       Impact factor: 14.870

7.  Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2.

Authors:  Shihui Sun; Hongjing Gu; Lei Cao; Qi Chen; Qing Ye; Guan Yang; Rui-Ting Li; Hang Fan; Yong-Qiang Deng; Xiaopeng Song; Yini Qi; Min Li; Jun Lan; Rui Feng; Yan Guo; Na Zhu; Si Qin; Lei Wang; Yi-Fei Zhang; Chao Zhou; Lingna Zhao; Yuehong Chen; Meng Shen; Yujun Cui; Xiao Yang; Xinquan Wang; Wenjie Tan; Hui Wang; Xiangxi Wang; Cheng-Feng Qin
Journal:  Nat Commun       Date:  2021-09-27       Impact factor: 14.919

  8 in total
  2 in total

1.  SARS-CoV-2 Omicron emergence urges for reinforced One-Health surveillance.

Authors:  Xavier Montagutelli; Sylvie van der Werf; Felix A Rey; Etienne Simon-Loriere
Journal:  EMBO Mol Med       Date:  2022-01-27       Impact factor: 12.137

2.  The recombinant variants of SARS-CoV-2: Concerns continues amid COVID-19 pandemic.

Authors:  Ranjan K Mohapatra; Venkataramana Kandi; Hardeep S Tuli; Chiranjib Chakraborty; Kuldeep Dhama
Journal:  J Med Virol       Date:  2022-04-27       Impact factor: 20.693

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.